Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- NetworkNewsWire Editorial Coverage
NEW YORK, May 20, 2021 /PRNewswire/ Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks at substances such as psilocybin, ketamine, DMT (dimethyltryptamine), LSD (lysergic acid diethylamide) and more, the potential for the compounds appeared to be widespread and even life-changing for many who struggled with notoriously difficult diseases such as depression, addiction, PTSD and more. And then the Federal Comprehensive Drug Abuse Prevention and Control Act of 1970, known as the Controlled Substance Act, took effect. For decades, the promise of these substances has remained ignored. However, with recent changes in legal guidelines and swings in public opinion, astute researchers - and companies - are showing renew
Zoned Properties Expands Real Estate Services with PropTech Data Projects streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CHARLESTON — Witnesses at the Cabell County and Huntington opioid case accusing wholesalers of fueling the opioid crisis in the area explored at trial Wednesday the history behind the opioid
CHARLESTON – The landmark federal trial against drug distributors McKesson, AmerisourceBergen and Cardinal Health over their role in the opioid epidemic began May 3 in Charleston.
During Monday s opening arguments for the bench trial at the federal courthouse, attorneys for the plaintiffs – the City of Huntington and the Cabell County Commission – told Senior U.S. District Judge David A. Faber they plan to put forth records and testimony showing the drug distributors knew their role in the crisis and could foresee the harm.
Meanwhile, the defendants said the plaintiffs couldn’t prove a direct causal link between distribution and the crisis. Williams
(AP Photo/Richard Vogel, File)
ST. PAUL, Minn. (CN) Two workers’ compensation insurers took on Minnesota’s medical marijuana program Monday at the state’s high court, arguing that continued federal prohibition of cannabis forbids them from paying for injured workers’ use of the drug for pain relief.
The Minnesota Supreme Court heard oral arguments early Monday in the cases of Susan Musta and Daniel Bierbach, two Minnesotans who sought to use medical marijuana to treat pain and disability from work-related injuries. Attorneys for their respective employers’ workers-compensation providers argued that coverage of medical marijuana would put insurers at risk of aiding and abetting a federal crime.